Showing posts with label microfilaria. Show all posts
Showing posts with label microfilaria. Show all posts

Thursday, 26 January 2023

Human Filariasis Diagnosed by Modified Knott Technique Randomly in Iraq: A Recent Study| Chapter 9 | Research Advances in Microbiology and Biotechnology Vol. 1

 The current study proposed to the detection of Microfilariae in persons for clinically unsuspected cases haphazard samples and for different ages; Applied reduced Knott technique for the first be present at Iraq; secondhand three types of stains for blood samples and condensation the results. A total of 103 blood samples active and patient people, the current study told to 37 (35.92%) were infected accompanying Filariasis. The current study recorded definite rates for four groups of ages: children (5-15 old age), young (16-27 year), Adult (28-49 old age) and old (50 old age & above) that the higher rate 55.55% in kids group. The detail of action test revealed non-meaningful differences ‘tween ages of positive samples for Filariasis. The current study disclosed out of 56 antitoxin samples of male 19 were positive (33.92%) and consumed 47 serum sample of female 18 were beneficial (38.29) for Filariasis. The statistic test told non-significant dissimilarities ‘tween male and female. The current study applied three types of stains Methylene vulgar, Giemsa and Lieshmen for compression; all ruling class appeared definite rates 38.15%, 35.71% and 23.07% respectively This study written three genera of filariae in accordance with the morphological traits (Brugia, Mansonella and Wucheraria).

Author(s) Details:

Afkar M. Hadi,
Iraq Natural History Research Center and Museum, University of Baghdad, Baghdad, Iraq.

Farah A. Al-Zahawi,
College of Medicine, University of Baghdad, Baghdad, Iraq.

Please see the link here: https://stm.bookpi.org/RAMB-V1/article/view/8990

Saturday, 14 January 2023

The Development of Long-term Vaccine against Viral Respiratory Infection is Difficult, What is the Enduring Solution?| Chapter 8 | Research Advances in Microbiology and Biotechnology Vol. 1

 Safe and persuasive vaccine formation is very main for viral respiratory contamination which is more an ambiguous process. There are many difficulties in the growth of effective vaccine in the way that regular mutations in viruses and lacking of general immunity. To prevent the difficulties in vaccine growth against viral respiratory contamination evolution of mucosal vaccine plays an main role in protection against these aggressive infections. In mucosal privilege, memory CD8+ T cell public play a crucial role in bearing high levels of gamma interferon (IFN-ϒ) and tumor loss factor (TNF) concede possibility be essential for protection as well as thought CD8+ T cell being able to evoke long-lived immunity. Hence, the theory related to the study novel form of combination in between viroporin as an antigenic ground or vaccine candidate secondhand with immunotherapeutic adjuvant (OX40 or OX40 and OX40L complex or IL12) concede possibility become to resolve the development of a general immunity holding vaccine.

Author(s) Details:

Rudra Prasad Roy,
Central Research Institute, Kasauli, India.

Laxmi Devi,
Central Research Institute, Kasauli, India.

Please see the link here: https://stm.bookpi.org/RAMB-V1/article/view/8989